Liangping Peng
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Multiple Myeloma Research and Treatments 3
-
- Adenosine and Purinergic Signaling 1
- Co-authors
- Siegfried JanzJoong Su KimRoberto D. PolakiewiczWan Cheung CheungMichael A. LindenSeong‐Su HanJing GuoYouzhi Dai
- Journals
- Molecular Cancer (3 papers)Journal of Clinical Investigation (2 papers)Journal of Colloid and Interface Science (1 paper)Cancer Research (1 paper)PubMed (2 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Liangping Peng
9 papers receiving 479 citations
Peers
Comparison fields: 5 of 70
- Hematology 112
- Genetics 60
- Oncology 151
- Immunology 112
- Renewable Energy, Sustainability and the Environment 80
Countries citing papers authored by Liangping Peng
This map shows the geographic impact of Liangping Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangping Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangping Peng more than expected).
Fields of papers citing papers by Liangping Peng
This network shows the impact of papers produced by Liangping Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangping Peng. The network helps show where Liangping Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liangping Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 116 | |
| 2 | 2010 | 105 | |
| 3 | 2006 | 11 | |
| 4 | 2005 | 83 | |
| 5 | 2005 | 6 | |
| 6 | 2004 | 79 | |
| 7 | 2004 | 73 | |
| 8 | [Screening and identification of human lung cancer-related antigens]. | 2002 | 5 |
| 9 | [Expression of NY-ESO-1 gene in human esophageal carcinoma and its cloning]. | 2002 | 4 |
About Liangping Peng
Liangping Peng is a scholar working on Hematology, Physiology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 9 papers that have together received 482 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Immune Cell Function and Interaction (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Multiple Myeloma Research and Treatments (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Adenosine and Purinergic Signaling (1 paper) and Advanced Photocatalysis Techniques (1 paper). The work is most often cited by research in Hematology (112 citations), Genetics (60 citations), Oncology (151 citations), Immunology (112 citations) and Renewable Energy, Sustainability and the Environment (80 citations). Liangping Peng has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Siegfried Janz, Joong Su Kim, Roberto D. Polakiewicz, Wan Cheung Cheung, Michael A. Linden, Seong‐Su Han, Jing Guo, Youzhi Dai, Minxing Chen and Lulu Zhou. Their work appears in journals such as Molecular Cancer, Journal of Clinical Investigation, Journal of Colloid and Interface Science, Cancer Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.